Guidance For Industry Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects
Contains Nonbinding Recommendations
TABLE OF CONTENTS
I. INTRODUCTION
II. OVERVIEW OF INVESTIGATOR RESPONSIBILITIES
III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES
A. Supervision of the Conduct of a Clinical Investigation
1. What Is Appropriate Delegation of Study-Related Tasks?
2. What Is Adequate Training?
3. What Is Adequate Supervision of the Conduct of an Ongoing Clinical Trial?
4. What Are an Investigator’s Responsibilities for Oversight of Other Parties Involved in the Conduct of a Clinical Trial?
B. Protecting the Rights, Safety, and Welfare of Study Subjects
1. Reasonable Medical Care Necessitated by Participation in a Clinical Trial.
2. Reasonable Access to Medical Care.
3. Protocol Violations that Present Unreasonable Risks.
ATTACHMENT A: COPY OF FORM 1572.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm or
Office of Communication, Training and Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
http://www.fda.gov/cber/guidelines.htm (Tel) 800-835-4709 or 301-827-1800 or
Office of Health and Industry Programs
Division of Small Manufacturers, International, and Consumer Assistance, HFZ-220
Center for Devices and Radiological Health
Food and Drug Administration
Tel: 1-800-638-2041
http://www.fda.gov/cdrh U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Procedural
October 2009
Clinical Research News
- Jan 16
- Jan 11
- Jan 10
- Dec 16
- Dec 13
- Dec 06
- Dec 06
- Dec 05
- Dec 05
- Nov 23
Предстоящие клинические испытания
-
NCT02408861РекрутингВИЧ-инфекция Продвинутое злокачественное солидное новообразование Саркома Капоши Карцинома легких Метастатическое злокачественное солидное новообразование Неоперабельное солидное новообразование Анальная карцинома Рецидивирующая классическая лимфома Ходжкина Рефрактерная классическая лимфома Ходжкина
-
NCT05052216РекрутингПедиатрическое обструктивное апноэ сна
-
NCT05710536РекрутингЗдоровый Vagina Laxity
-
NCT05709327Еще не набирают
-
NCT01604512Рекрутинг
-
NCT03328078РекрутингРефрактерная гематологическая злокачественность Рецидив гематологического злокачественного новообразования
-
NCT05711251Еще не набираютФизическое бездействие
-
NCT05711056Еще не набираютИспользование опиоидов Злоупотребление опиоидами
-
NCT05710887Еще не набираютСуицидальные мысли Сильное депрессивное расстройство Резистентная к лечению депрессия
Clinical Research Jobs
-
Associate CDM Programmer
-
Sr Procurement Program Manager
-
Associate Director, Market Access Communications
-
CRA (Level II) - Transferable Skills (APAC)
-
Research Assoc II Evidera
-
Sr Programmer Analyst II - SDTM, TLF, ADAM- Open for Remote/Flex/Officebase
-
Sr Clin Data Team Lead
-
Senior Biostatistician - Taiwan
-
UNC Chapel Hill STEM & All Majors Virtual Career Fair Attendee
-
University of Kansas 2023 Career & Internship Expo